Clinical and immunological evaluation of anti-apoptosis protein, survivin-derived peptide vaccine in phase I clinical study for patients with advanced or recurrent breast cancer

por Tsuruma, Tetsuhiro, Iwayama, Yuji, Ohmura, Tosei, Katsuramaki, Tadashi, Hata, Fumitake, Furuhata, Tomohisa, Yamaguchi, Koji, Kimura, Yasutoshi, Torigoe, Toshihiko, Toyota, Nobuhiko, Yagihashi, Atsuhito, Hirohashi, Yoshihiko, Asanuma, Hiroko, Shimozawa, Kumiko, Okazaki, Minoru, Mizushima, Yasuhiro, Nomura, Naohiro, Sato, Noriyuki, Hirata, Koichi
Publicado 2008

Phase I clinical study of anti-apoptosis protein, survivin-derived peptide vaccine therapy for patients with advanced or recurrent colorectal cancer

por Tsuruma, Tetsuhiro, Hata, Fumitake, Torigoe, Toshihiko, Furuhata, Tomohisa, Idenoue, Satomi, Kurotaki, Takehiro, Yamamoto, Masaaki, Yagihashi, Atsuhito, Ohmura, Tosei, Yamaguchi, Koji, Katsuramaki, Tadashi, Yasoshima, Takahiro, Sasaki, Kazuaki, Mizushima, Yasuhiro, Minamida, Hidetoshi, Kimura, Hiromichi, Akiyama, Morifumi, Hirohashi, Yoshihiko, Asanuma, Hiroko, Tamura, Yasuaki, Shimozawa, Kumiko, Sato, Noriyuki, Hirata, Koichi
Publicado 2004